Sanofi pulls popular heartburn drug Zantac in US, Canada

In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac.

New Delhi: Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.

The French company on Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.

Read Also: Amid cancer scares GSK recalls heartburn drug Zantac as a precautionary measure

In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.

Several drugstore chains have already removed Zantac and generic versions from store shelves.

Read Also: Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators